SCHEMBL5739693

SCHEMBL5739693

CCC(c1nc2onc(C)c2c(=O)n1Cc1ccccc1)N(CCCNC(=O)O)C(=O)c1ccc(C)cc1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040565 0.96 KIF11 (0.76) KIF11
SCHEMBL4036121 0.95 KIF11 (0.76) KIF11
SCHEMBL4036341 0.95 KIF11 (0.75) KIF11
SCHEMBL4040359 0.94 KIF11 (0.74) KIF11
SCHEMBL4037806 0.93 KIF11 (0.73) KIF11
SCHEMBL4038393 0.93 KIF11 (0.72) KIF11
SCHEMBL4044119 0.93 KIF11 (0.71) KIF11
SCHEMBL4859184 0.93 KIF11 (0.81) KIF11
SCHEMBL4038059 0.92 KIF11 (0.88) KIF11
SCHEMBL4039867 0.92 KIF11 (0.70) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628981-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004106492-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-09 WO disclosed